Drugs & Cosmetics
-
Franchise India Bureau Apr 06 2018 - 1 min readLife sciences and consumer services provider C3i Solutions which is the subsidiary of US-based drug maker Merck & Co. has received acquisition confirmation from IT firm HCL Technologies for $60 million (Rs 390 crore) in cash, the company said in a stock-exchange disclosure. HCL Technologies will acquire 100% stake in C3i ...
-
Franchise India Bureau Mar 26 2018 - 1 min readDrug firm Zydus Cadila has received the final nod from US health regulator to market Metoprolol Succinate extended-release tablets, used for treatment of various cardiac conditions, in the American market. The product will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad, Zydus Cadila said in a statement.
-
Franchise India Bureau Mar 22 2018 - 1 min readSuven Life Sciences has claimed to have been granted a patent each by Norway, South Korea and Singapore corresponding to new chemical entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases. As per the filing registered by the company, the patents are valid till 2027, 2034 and 2036, respectively. ...
-
Franchise India Bureau Mar 15 2018 - 1 min readStrides Shasun has claimed to have received approval from the US health regulator for its generic Efavirenz tablet used for treatment of HIV Type-1 infected adults and adolescents. The company in a regulatory filing said, “The approval granted to the company's wholly-owned subsidiary Strides Pharma Global Pte by the US Food ...
-
Franchise India Bureau Feb 28 2018 - 2 min readRivals in the past, Swiss drug maker Roche Pharma and India’s third-largest drug maker have combined to promote and distribute tocilizumab (Actemra) and Syndyma, the 2nd brand of Roche’s cancer therapy, bevacizumab (Avastin) in India. In a joint statement, the company said this partnership is in line with Roche and Cipla’s ...